Animal models of drug-resistant epilepsy

Epileptic Disorders

Volumn 14, Issue 3, 2012, Pages 226-234

  Potschka, Heidrun ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

6 Hz model; Animal models; Drug refractoriness; Drug resistance; Epilepsy; Intractability; Kindling; Pharmacoresistance; Status epilepticus

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ANTICONVULSIVE AGENT;

CONFERENCE PAPER; DISEASE MODEL; DOG; DRUG EFFICACY; DRUG RESPONSE; ELECTROSTIMULATION; EPILEPSY; EPILEPTIC STATE; HUMAN; KINDLING; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANIMAL MODEL; DRUG RESISTANCE; STATUS EPILEPTICUS;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; EPILEPSY; HUMANS; KINDLING, NEUROLOGIC; MODELS, ANIMAL; STATUS EPILEPTICUS;

EID: 84867416150     PISSN: 12949361     EISSN: 19506945     Source Type: Journal    
DOI: 10.1684/epd.2012.0532     Document Type: Conference Paper

References (45)

1. Barton ME, Klein BD, Wolf HH, White HS. Pharmacological characterization of the 6-Hz psychomotor seizure model of partial epilepsy. Epilepsy Res 2001; 47: 217-27. (Pubitemid 34008465)
2. Bethmann K, Brandt C, Loscher W. Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy. Epilepsia 2007; 48: 816-26. (Pubitemid 46587623)
3. Bethmann K, Fritschy JM, Brandt C, Loscher W. Antiepileptic drug resistant rats differ from drug responsive rats in GABA A receptor subunit expression in a model of temporal lobe epilepsy. Neurobiol Dis 2008; 31: 169-87.
4. Blanco MM, dos Santos Jr. JG, Perez-Mendes P, et al.Assessment of seizure susceptibility in pilocarpine epileptic and nonepileptic Wistar rats and of seizure reinduction with pentylenetetrazole and electroshock models. Epilepsia2009; 50: 824-31.
5. Brandt C, Volk HA, Loscher W. Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus. Epilepsia2004; 45: 1488-97. (Pubitemid 39648273)
6. Brandt C, Bethmann K, Gastens AM, Loscher W. The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy. Neurobiol Dis 2006; 24: 202-11. (Pubitemid 44416217)
7. Bartmann H, Fuest C, la Fougere C, et al. Imaging of P-glycoprotein- mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy. Epilepsia 2010; 51: 1780-90.
8. Dewey CW, Cerda-Gonzalez S, Levine JM, et al. Pregabalin as an adjunct to phenobarbital, potassium bromide, or a combination of phenobarbital and potassium bromide for treatment of dogs with suspected idiopathic epilepsy. J AmVet Med Assoc 2009; 235: 1442-9.
9. Duncan GE, Kohn H. The novel antiepileptic drug lacosamide blocks behavioral and brain metabolic manifestations of seizure activity in the 6-Hz psychomotor seizure model. Epilepsy Res 2005; 67: 81-7. (Pubitemid 41578983)
10. Ebert U, Reissmuller E, Loscher W. The new antiepileptic drugs lamotrigine and felbamate are effective in phenytoin-resistant kindled rats. Neuropharmacology 2000; 39: 1893-903. (Pubitemid 30398493)
11. Gastens AM, Brandt C, Bankstahl JP, Loscher W. Predictors of pharmacoresistant epilepsy: pharmacoresistant rats differ from pharmacoresponsive rats in behavioral and cognitive abnormalities associated with experimentally induced epilepsy. Epilepsia 2008; 49: 1759-76.
12. Germano IM, Sperber EF. Transplacentally induced neuronal migration disorders: an animal model for the study of the epilepsies. J Neurosci Res 1998; 51: 473-88. (Pubitemid 28106708)
13. Glien M, Brandt C, Potschka H, Loscher W. Effects of the novel antiepileptic drug levetiracetamonspontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy. Epilepsia 2002; 43: 350-7. (Pubitemid 34297172)
14. Jambroszyk M, Tipold A, Potschka H. Add-on treatment with verapamil in pharmacoresistant canine epilepsy. Epilepsia2011; 52: 284-91.
15. Jeub M, Beck H, Siep E, U et al. Effect of phenytoin on sodium and calcium currents in hippocampal CA1 neurons of phenytoin-resistant kindled rats. Neuropharmacology 2002; 42: 107-16. (Pubitemid 34062826)
16. Loscher W. Animal models of intractable epilepsy. Prog Neurobiol1997; 53: 239-58. (Pubitemid 27436002)
17. Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res2002; 50: 105-23. (Pubitemid 34876591)
18. Loscher W. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 2011; 20: 359-68.
19. Loscher W, Rundfeldt C. Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats. J Pharmacol Exp Ther 1991; 258: 483-9.
20. Loscher W, Brandt C. High seizure frequency prior to antiepileptic treatment is a predictor of pharmacoresistant epilepsy in a rat model of temporal lobe epilepsy. Epilepsia2010; 51: 89-97.
21. Loscher W, Jackel R, Czuczwar SJ. Is amygdala kindling in rats a model for drug-resistant partial epilepsy? Exp Neurol1986; 93: 211-26. (Pubitemid 16059784)
22. Loscher W, Rundfeldt C, Honack D. Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy. Epilepsy Res1993; 15: 207-19. (Pubitemid 23271762)
23. Loscher W, Reissmuller E, Ebert U. Anticonvulsant efficacy of gabapentin and levetiracetam in phenytoin-resistant kindled rats. Epilepsy Res 2000; 40: 63-77. (Pubitemid 30193363)
24. Loscher W, Potschka H, Rieck S, Tipold A, Rundfeldt C. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures. Epilepsia2004; 45: 1228-39. (Pubitemid 39350335)
25. Pekcec A, Unkruer B, Stein V, et al. Over-expression of P-glycoprotein in the canine brain following spontaneous status epilepticus. Epilepsy Res 2009; 83: 144-51.
26. Platt SR, Adams V, Garosi LS, et al. Treatment with gabapentin of 11 dogs with refractory idiopathic epilepsy. Vet Rec2006; 159: 881-4. (Pubitemid 46111360)
27. Postma T, Krupp E, Li XL, Post RM, Weiss SR. Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy. Epilepsia 2000; 41: 1514-21. (Pubitemid 32002723)
28. Potschka H, Volk HA, Loscher W. Pharmacoresistance and expression of multidrug transporter P-glycoprotein in kindled rats. Neuroreport 2004; 15: 1657-61. (Pubitemid 38971189)
29. Reissmuller E, Ebert U, Loscher W. Anticonvulsant efficacy of topiramate in phenytoin-resistant kindled rats. Epilepsia2000; 41: 372-9. (Pubitemid 30196600)
30. Rogawski MA, Johnson MR. Intrinsic severity as a determinant of antiepileptic drug refractoriness. Epilepsy Curr 2008; 8: 127-30.
31. Rundfeldt C, Honack D, Loscher W. Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats. Neuropharmacology 1990; 29: 845-51. (Pubitemid 20276406)
32. Schmidt D, Loscher W. New developments in antiepileptic drug resistance: an integrative view. Epilepsy Curr 2009; 9: 47-52.
33. Schwartz-Porsche D, Loscher W, Frey HH. Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: a comparison. J Vet Pharmacol Ther 1985; 8: 113-9.
34. Serbanescu I, Cortez MA, McKerlie C, Snead OC 3rd. Refractory atypical absence seizures in rat: a two hit model. EpilepsyRes 2004; 62: 53-63. (Pubitemid 39424191)
35. Shannon HE, Eberle EL, Peters SC. Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats. Neuropharmacology 2005; 48: 1012-20. (Pubitemid 40602609)
36. Smyth MD, Barbaro NM, Baraban SC. Effects of antiepileptic drugs on induced epileptiform activity in a rat model of dysplasia. Epilepsy Res 2002; 50: 251-64. (Pubitemid 35015209)
37. Srivastava AK, White HS. Retigabine decreases behavioral and electrographic seizures in the lamotrigine. Resistant amygdale kindled rat model of pharmacoresistant epilepsy. Epilepsia 2005; 46: 217-8.
38. Srivastava AK, White HS. Felbamate is effective against behavioural and the electrographic seizures in the lamotrigine-resistant amygdale kindled rat model of refractory epilepsy. Epilepsia 2006; 47: 321-2.
39. Srivastava AK, Franklin MR, Palmer BS, et al. Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala-kindled rats. Epilepsia2004; 45 (suppl.7): 12.
40. Srivastava AK, Ugarte I, White HS. Levetiracetam decreases behavioral and electrographic seizures in the lamotrigine-resistant amygdale kindled rat model of pharma-coresistant epilepsy. Epilepsia 2007; 48: 364-5.
41. Toman JE. Neuropharmacologic considerations in psychic seizures. Neurology 1951; 1: 444-60.
42. Volk HA, Loscher W. Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures. Brain 2005; 128: 1358-68. (Pubitemid 40826189)
43. Volk HA, Arabadzisz D, Fritschy JM, Brandt C, Bethmann K, Loscher W. Antiepileptic drug-resistant rats differ from drug-responsive rats in hippocampalneurodegenerationand GABA(A) receptor ligand binding in a model of temporal lobe epilepsy. Neurobiol Dis 2006; 21: 633-46. (Pubitemid 43277545)
44. Volk HA, Matiasek LA, Lujan Feliu-Pascual A, Platt SR, Chandler KE. The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs. Vet J 2008; 176: 310-9. (Pubitemid 351611920)
45. von Klopmann T, Rambeck B, Tipold A. Prospective study of zonisamide therapy for refractory idiopathic epilepsy in dogs. J Small Anim Pract 2007; 48: 134-8. (Pubitemid 46392409)